These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 9235189)

  • 41. Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome--results of a retrospective study.
    Wiegel T; Lohm G; Bottke D; Höcht S; Miller K; Siegmann A; Schostak M; Neumann K; Hinkelbein W
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1009-16. PubMed ID: 18963539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prostate-specific antigen in urine.
    Breul J; Pickl U; Hartung R
    Eur Urol; 1994; 26(1):18-21. PubMed ID: 7523129
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Prostate-specific antigen or PSA. Facts and probabilities].
    Boccon-Gibod L
    Presse Med; 1995 Oct; 24(32):1471-2. PubMed ID: 8545344
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Urinary PSA (uPSA) in the monitoring of local recurrence following radical prostatectomy].
    Marzano D; Cianetti A; Annunziata S; Salvatore C; Perrone M; Lentini M
    Arch Ital Urol Androl; 1997 Feb; 69 Suppl 1():105-8. PubMed ID: 9181913
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sensitive detection of prostatic hematogenous tumor cell dissemination using prostate specific antigen and prostate specific membrane-derived primers in the polymerase chain reaction.
    Israeli RS; Miller WH; Su SL; Samadi DS; Powell CT; Heston WD; Wise GJ; Fair WR
    J Urol; 1995 Mar; 153(3 Pt 1):573-7. PubMed ID: 7532229
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical relevance of genetic instability in prostatic cells obtained by prostatic massage in early prostate cancer.
    Thuret R; Chantrel-Groussard K; Azzouzi AR; Villette JM; Guimard S; Teillac P; Berthon P; Houlgatte A; Latil A; Cussenot O
    Br J Cancer; 2005 Jan; 92(2):236-40. PubMed ID: 15655554
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Urine PSA is not useful for detecting prostate cancer?
    Irani J
    Urology; 1998 Aug; 52(2):350-1. PubMed ID: 9697814
    [No Abstract]   [Full Text] [Related]  

  • 48. Supersensitive detection of prostate-specific antigen in lyophilisation-concentrated serum.
    Huland E; Haese A; Huland H
    Int J Oncol; 1996 Oct; 9(4):593-601. PubMed ID: 21541556
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early postoperative peripheral blood reverse transcription PCR assay for prostate-specific antigen is associated with prostate cancer progression in patients undergoing radical prostatectomy.
    Shariat SF; Kattan MW; Song W; Bernard D; Gottenger E; Wheeler TM; Slawin KM
    Cancer Res; 2003 Sep; 63(18):5874-8. PubMed ID: 14522912
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of factors predicting response to adjuvant radiation therapy in patients with positive margins after radical prostatectomy.
    Kamat AM; Babaian K; Cheung MR; Naya Y; Huang SH; Kuban D; Babaian RJ
    J Urol; 2003 Nov; 170(5):1860-3. PubMed ID: 14532793
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Post-treatment PSA, indicator of radical treatment effectiveness of localized cancer of the prostate].
    Ravery V; Hermieu JF; Hoffmann P; Delmas V; Boccon-Gibod L
    Prog Urol; 1996 Dec; 6(6):981-6. PubMed ID: 9235189
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The significance of recurrent PSA after radical prostatectomy: benign versus malignant sources.
    Ravery V
    Semin Urol Oncol; 1999 Aug; 17(3):127-9. PubMed ID: 10462314
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.